PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,404 | -1.9% | 2,183 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $13,666 | -34.2% | 2,183 | -8.5% | 0.00% | 0.0% |
| Q4 2022 | $20,767 | -26.9% | 2,387 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $28,405 | -16.5% | 2,387 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $34,015 | -14.8% | 2,387 | +24.5% | 0.00% | 0.0% |
| Q1 2022 | $39,912 | -78.7% | 1,917 | -76.4% | 0.00% | -66.7% |
| Q4 2021 | $187,664 | -22.5% | 8,124 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $242,095 | +68.9% | 8,124 | +86.4% | 0.00% | +100.0% |
| Q1 2021 | $143,368 | -46.5% | 4,359 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $268,122 | – | 4,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |